Brett King

27PUBLICATIONS
111CO-AUTHORS
Traditional Chinese medicine and treatmentsSociological methodology and research methodsInternational arbitrationBiologically active moleculesAvionics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jul 23, 2025
Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024.

Nekma Meah, Jane Li, Dmitri Wall

|Apr 11, 2025
Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment.

Brett King, Arash Mostaghimi, Yutaka Shimomura

|Mar 27, 2025
Efficacy and safety of etrasimod in alopecia areata: A multicentre, randomized, double-blind, placebo-controlled, Phase 2 study.

B King, N Mesinkovska, M Senna

|Feb 17, 2025
Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme.

B King, P Mirmirani, K Lo Sicco

|Nov 21, 2024
Continued treatment with baricitinib results in meaningful scalp responses among scalp non-responder patients with eyebrow/eyelash regrowth in the first year.

Arash Mostaghimi, Matthias Augustin, Kazutoshi Harada

Pageof 5